ASX - Delayed Quote AUD

Elixinol Wellness Limited (EXL.AX)

0.0060 +0.0020 (+50.00%)
At close: April 26 at 4:10 PM GMT+10
Key Events
Loading Chart for EXL.AX
DELL
  • Previous Close 0.0040
  • Open 0.0050
  • Bid 0.0050 x 14280600
  • Ask 0.0060 x 19968800
  • Day's Range 0.0050 - 0.0060
  • 52 Week Range 0.0040 - 0.0200
  • Volume 8,308,682
  • Avg. Volume 3,126,767
  • Market Cap (intraday) 7.806M
  • Beta (5Y Monthly) 2.07
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Feb 28, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 0.03

Elixinol Wellness Limited, through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.

www.elixinolwellness.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EXL.AX

Performance Overview: EXL.AX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EXL.AX
50.00%
S&P/ASX 200 [XJO]
0.20%

1-Year Return

EXL.AX
70.00%
S&P/ASX 200 [XJO]
3.55%

3-Year Return

EXL.AX
96.67%
S&P/ASX 200 [XJO]
7.53%

5-Year Return

EXL.AX
99.85%
S&P/ASX 200 [XJO]
18.64%

Compare To: EXL.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EXL.AX

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    7.81M

  • Enterprise Value

    8.36M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.44

  • Price/Book (mrq)

    1.21

  • Enterprise Value/Revenue

    1.01

  • Enterprise Value/EBITDA

    -1.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -90.79%

  • Return on Assets (ttm)

    -29.99%

  • Return on Equity (ttm)

    -96.12%

  • Revenue (ttm)

    8.27M

  • Net Income Avi to Common (ttm)

    -7.51M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    708k

  • Total Debt/Equity (mrq)

    19.53%

  • Levered Free Cash Flow (ttm)

    -2.11M

Research Analysis: EXL.AX

Analyst Price Targets

0.03
0.03 Average
0.0060 Current
0.03 High
 

Fair Value

 

Company Insights: EXL.AX

People Also Watch